U.S. administers 359.6 million doses of COVID-19 vaccines – CDC

FILE PHOTO: A syringe is filled with a dose of Pfizer’s COVID-19 vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermid(Reuters) – The United States has administered 359,623,380 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 422,175,735 doses, the U.S. […]

» Read more

SARS-CoV-2 antibodies found to neutralize bat coronavirus (RaTG13) in new study

A striking new study examines how far antibodies elicited by vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or by natural infection, can neutralize the closely related bat coronavirus (CoV) RaTG13. The study, available as a preprint on the bioRxiv* server, shows that the bat CoV is, unexpectedly, neutralized more efficiently by antisera raised by SARS-CoV-2 than the […]

» Read more

Research finds hundreds of millions of Africans lack basic means of preventing SARS-coV-2 transmission

Millions of people across the African continent are at risk of contracting COVID-19 because of a lack of the most basic public health tools to protect themselves—including the essentials of soap and water. These measures—known as non-pharmacological public health interventions (NPIs), and including physical distancing or isolation at home to prevent transmission—are among the simplest and least expensive methods to […]

» Read more

Hearing loss could be cause of depression in older people

University of Manchester researchers have discovered that hearing loss may act as a cause of depression in older people. And those in the lowest wealth groups, they found, had up to twice the relative risk of developing depression than those in the highest wealth quintiles, as hearing loss disproportionally affected their quality of life. Published in Social Psychiatry and Psychiatric […]

» Read more

Early clinical trial data in for whole virus COVID-19 vaccine candidate

The currently deployed coronavirus disease 2019 (COVID-19) vaccines are either mRNA or adenovirus vector-based, though several others have been or are in development. Several whole-virion inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have demonstrated good efficacy in early clinical trials, particularly in combination with an aluminum adjuvant (a substance that gives a stronger immune response), which is more […]

» Read more

Digital health is a vital tool: How to make it more sustainable

The pandemic has shown us the extraordinary potential of digital health to fight global health inequalities by providing expanded access to healthcare: as well as by better informing our responses to health crises. Tools such as wearable monitoring devices, video consultations, and even chat-bots driven by AI can provide care from a distance and often cost less than a face-to-face […]

» Read more
1 743 744 745 746 747 1,330